- Filed
- Aug 28, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 10, 2024 | 47.95M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2024 | 1.97M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 1.08M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $104K |
| Capex | Q1 2024 · Mar 31, 2023 | $277K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$8.64M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$10.32M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $38.96M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $38.64M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $29.68M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $38.04M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$66.16M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$71.3M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$49.66M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$32.31M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $66.22M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $65.43M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $126.15M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $143.01M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $53.64M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $64.82M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $59.99M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $71.71M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | $0.96 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$17.09 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | $1.04 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$17.09 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $6.39M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $5.31M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $5.73M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $7.85M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | $2M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$17.8M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$11.39M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$13.89M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $6.87M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $11.13M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $2.52M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $2.94M |
| Revenue | Q1 2024 · Mar 31, 2024 | $9.39M |
| Revenue | Q1 2024 · Mar 31, 2023 | $14.07M |